close 74% rachunków inwestorów detalicznych odnotowuje straty w wyniku handlu kontraktami CFD u niniejszego dostawcy. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 74% rachunków inwestorów detalicznych odnotowuje straty w wyniku handlu kontraktami CFD u niniejszego dostawcy. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

Strona główna・Stock List・Karyopharm Therapeutics Inc
Search

Karyopharm Therapeutics Inc

Closed

SectorHealthcare

8.74 6.59

Strong Buy

Price update 11 mar 2026, 19:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

7.88

Max

8.8

Key metrics

By Trading Economics

Income

-69M

-102M

Sales

-10M

34M

EPS

-5.69

Profit margin

-299.886

Employees

228

EBITDA

4.7M

-18M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+136.94% upside

Market Stats

By TradingEconomics

Market Cap

-1.4M

156M

Previous open

2.15

Previous close

8.74

News Sentiment

By Acuity

75%

25%

316 / 351 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

5.9501 / 7.66 Support & Resistance

Karyopharm Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

11 mar 2026, 19:18 UTC

Major Market Movers

Stryker Shares Down After Cyberattack Tied to Iran-Linked Group

DJ

Read

11 mar 2026, 23:54 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Read

11 mar 2026, 23:54 UTC

Market Talk

Nikkei May Decline on Energy Costs Concerns -- Market Talk

DJ

Read

11 mar 2026, 23:51 UTC

Market Talk

Gold Falls as Rising Oil Prices Spur Inflation Worries -- Market Talk

DJ

Read

11 mar 2026, 23:41 UTC

Market Talk

REA Bull Sees Potential Upside to Yield Guidance -- Market Talk

DJ

Read

11 mar 2026, 23:37 UTC

Market Talk
Major News Events

Oil Futures Rise Amid Ongoing Middle East Conflict -- Market Talk

DJ

Read

11 mar 2026, 23:17 UTC

Major News Events

Front-Month WTI Crude Oil Futures Rise 5.5% to $92.05/bbl

DJ

Read

11 mar 2026, 23:17 UTC

Major News Events

Front-Month Crude Oil Futures Rise Amid Ongoing Middle East Conflict

DJ

Read

11 mar 2026, 22:29 UTC

Market Talk

Australia Shares Set to Fall in Early Trade -- Market Talk

DJ

Read

11 mar 2026, 21:47 UTC

Earnings

Liontown Resources: Market Tailwinds Strengthening Outlook

DJ

Read

11 mar 2026, 21:46 UTC

Earnings

Liontown Resources: 4 Mln Ton Per Annum Expansion Study Underway

DJ

Read

11 mar 2026, 21:45 UTC

Earnings

Liontown Resources Says FY26 Guidance Unchanged

DJ

Read

11 mar 2026, 21:45 UTC

Earnings

Liontown Resources 1H Unit Operating Costs A$985/Ton

DJ

Read

11 mar 2026, 21:44 UTC

Earnings

Liontown Resources 1H Underlying Ebitda Loss A$7.7 Million

DJ

Read

11 mar 2026, 21:43 UTC

Earnings

Liontown Resources 1H Revenue A$207.5 Million

DJ

Read

11 mar 2026, 21:43 UTC

Earnings

Liontown Resources 1H Net Loss A$184 Million

DJ

Read

11 mar 2026, 21:12 UTC

Acquisitions, Mergers, Takeovers

Netflix Rival Strikes Deal With Google in Battle for AI Content -- Barrons.com

DJ

Read

11 mar 2026, 21:10 UTC

Earnings

Vista Gold FY25 Loss $7.5M >VGZ

DJ

Read

11 mar 2026, 21:10 UTC

Earnings

Vista Gold FY25 Loss/Shr 6c >VGZ

DJ

Read

11 mar 2026, 20:50 UTC

Market Talk
Major News Events

Basic Materials Roundup: Market Talk

DJ

Read

11 mar 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

DJ

Read

11 mar 2026, 20:27 UTC

Acquisitions, Mergers, Takeovers

Papa John's Draws Fresh Takeover Interest -- 2nd Update

DJ

Read

11 mar 2026, 20:26 UTC

Earnings

These Stocks Are Today's Movers: Oracle, UniFirst, Fair Isaac, Nebius, AeroVironment, Campbell's, and More -- Barrons.com

DJ

Read

11 mar 2026, 20:19 UTC

Major News Events

The Strait of Hormuz Could Take Weeks -- Even Months -- to Reopen, Military Experts Say -- Barrons.com

DJ

Read

11 mar 2026, 20:15 UTC

Earnings

This Physical AI Stock Jumped on Earnings. The Robots Are Coming. -- Barrons.com

DJ

Read

11 mar 2026, 20:12 UTC

Major News Events

Stock Market Today: Oil Prices Push Higher Despite IEA Oil Release Headline -- WSJ

DJ

Read

11 mar 2026, 19:31 UTC

Market Talk
Major News Events

Oil Futures Gain Despite IEA's Planned Release of Reserves -- Market Talk

DJ

Read

11 mar 2026, 19:01 UTC

Market Talk
Major News Events

U.S. Natural Gas Gains With Middle East Conflict in View -- Market Talk

DJ

Read

11 mar 2026, 18:59 UTC

Acquisitions, Mergers, Takeovers

Berkshire's Deal for Occidental Chemicals Unit Is a Winner as Chemical Stocks Surge -- Barrons.com

DJ

Read

11 mar 2026, 18:43 UTC

Major News Events

Chubb Named Lead Insurer for U.S. Plan to Protect Oil Tankers in Strait of Hormuz -- Barrons.com

DJ

Read

Peer Comparison

Price change

Karyopharm Therapeutics Inc Forecast

Price Target

By TipRanks

136.94% upside

12 Months Forecast

Average 19.5 USD  136.94%

High 28 USD

Low 12 USD

Based on 5 Wall Street analysts offering 12 month price targets forKaryopharm Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Based on 5 analysts giving stock ratings to Karyopharm Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

5.9501 / 7.66Support & Resistance

Short Term

Bullish Evidence

Recent bullish events outweigh bearish events.

Intermediate Term

Strong Bearish Evidence

All events are bearish.

Long Term

No Evidence

There are no events.

Sentiment

By Acuity

316 / 351 Ranking in Healthcare

News Sentiment

Very Strong Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

998.88

↓-0.19%

JNJ

Johnson and Johnson

243.11

↓-0.23%

ABBV

AbbVie Inc

227.62

↑ +0.42%

NVS

Novartis AG

155.44

↓-3.77%

AZN

AstraZeneca PLC

192.99

↓-1.1%
help-icon Live chat